Ratings Toray Industries, Inc.

Equities

3402

JP3621000003

Commodity Chemicals

Market Closed - Japan Exchange Other stock markets 07:30:00 18/06/2025 BST			5-day change	1st Jan Change
985.60 ^JPY	+0.66%		+0.98%	-1.59%

06-13	Toray Industries, Inc., Q3 2025 Earnings Call, Feb 12, 2025
06-09	Fuso Pharma Appeals 7.47 Billion Yen Patent Ruling to Japan's Supreme Court	MT

Summary: Toray Industries, Inc.

The company presents an interesting fundamental situation from a short-term investment perspective.

Highlights: Toray Industries, Inc.

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company's share price in relation to its net book value makes it look relatively cheap.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

Weaknesses: Toray Industries, Inc.

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company does not generate enough profits, which is an alarming weak point.
The company is highly valued given the cash flows generated by its activity.

Ratings Chart: Toray Industries, Inc.

Source: Surperformance

ESG chart: Toray Industries, Inc.

Source: MSCI

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Fundamentals (Composite)	Global Valuation (Composite)	Financial estimates revisions (Composite)	Capi.($)
	TORAY INDUSTRIES, INC.				10.36B
	AIR LIQUIDE				121B
	SABIC				44.3B
	WANHUA CHEMICAL GROUP CO., LTD.				23.59B
	LYONDELLBASELL INDUSTRIES N.V.				19.15B
	NINGXIA BAOFENG ENERGY GROUP CO., LTD.				16.77B
	HENGLI PETROCHEMICAL CO.,LTD.				14.57B
	RONGSHENG PETROCHEMICAL CO., LTD.				11.11B
	Average				32.62B
	Weighted average by Cap.

See all sector ratings

Investor (Composite)

Trader (Composite)

ESG MSCI

AAA

Financials

Revenue growth

EPS growth

Capital Efficiency (Composite)

Net Margin

Financial Health (Composite)

Valuation

P/E

EV/Revenue

EV/EBITDA

PBR

Dividend Yield

Revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

Revenue revisions (1 month)

EPS revisions (1 year)

EPS revisions (4 months)

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (4 months)

Analysts' target price evolution (1 year)

Business Predictability

Surprise rates

Analysts' coverage

Analysts' recommendations divergence

Analysts' Target price divergence

Financial estimates divergence

ESG

Environment

Social

Governance

Controversy

Ethical controversies

Human rights controversies

Tax subsidies controversies

Sharia compliant

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes